Bill Text: AZ HB2263 | 2012 | Fiftieth Legislature 2nd Regular | Introduced
Bill Title: Methamphetamine precursor logging system
Spectrum: Slight Partisan Bill (Republican 6-2)
Status: (Passed) 2012-05-11 - Governor Signed [HB2263 Detail]
Download: Arizona-2012-HB2263-Introduced.html
REFERENCE TITLE: methamphetamine precursor logging system |
State of Arizona House of Representatives Fiftieth Legislature Second Regular Session 2012
|
HB 2263 |
|
Introduced by Representatives Carter, Farley, Stevens: Brophy McGee, Goodale, Hobbs, Urie, Yee
|
AN ACT
Amending title 32, chapter 18, article 3, Arizona Revised Statutes, by adding section 32-1977; relating to the state board of pharmacy.
(TEXT OF BILL BEGINS ON NEXT PAGE)
Be it enacted by the Legislature of the State of Arizona:
Section 1. Title 32, chapter 18, article 3, Arizona Revised Statutes, is amended by adding section 32-1977, to read:
32-1977. Sale of methamphetamine precursors; electronic sales tracking system; violation; classification; state preemption
A. A retailer shall not sell to the same person, and a person shall not purchase, products containing more than three and six-tenths grams per day or more than nine grams per thirty day period of ephedrine or pseudoephedrine base, or their salts, isomers or salts of isomers. These limits apply to the total amount of base ephedrine and pseudoephedrine contained in the products and not to the overall weight of the products.
B. The retailer must keep nonprescription products containing pseudoephedrine or ephedrine behind the counter or in a locked case where a customer does not have direct access.
C. The retailer shall require a person purchasing a nonprescription product that contains pseudoephedrine or ephedrine to present valid government issued photo identification at the point of sale. The retailer shall record all of the following:
1. The name and address of the purchaser.
2. The name and quantity of product purchased.
3. The date and time of purchase.
4. Purchaser identification type and number.
D. Beginning January 1, 2013, before completing a sale pursuant to this section, a retailer must use an electronic sales tracking system and electronically submit the required information to the national precursor log exchange administered by the national association of drug diversion investigators if the system is available to retailers without a charge for access.
E. If a retailer that sells a nonprescription product containing pseudoephedrine or ephedrine experiences mechanical or electronic failure of the electronic sales tracking system and is unable to comply with the electronic sales tracking requirements of this section, the retailer must maintain a written log or an alternative electronic recordkeeping mechanism until the retailer is able to comply with the electronic sales tracking system requirements.
F. The national association of drug diversion investigators shall forward state transaction records in the national precursor log exchange to the appropriate state agency each week and provide real-time access to the national precursor log exchange information through the national precursor log exchange online portal to law enforcement in this state as authorized by the agency.
G. The system prescribed in this section must be capable of generating a stop sale alert notification that completion of the sale would result in the retailer or purchaser violating the quantity limits prescribed in this section. The retailer may not complete the sale if the system generates a stop sale alert. The electronic sales tracking system prescribed in this section must contain an override function that may be used by dispensers of ephedrine or pseudoephedrine who have a reasonable fear of imminent bodily harm if they do not complete a sale. The system must log each instance that a retailer uses the override function.
H. A person who violates this section is guilty of a class 3 misdemeanor, punishable by fine only. If a product is dispensed in violation of subsection A of this section, the owner or operator of the wholesale or retail establishment dispensing the product is considered to be in violation of subsection A of this section.
I. This section does not apply to a person who obtains the product pursuant to a valid prescription order.
J. The reporting of sales of ephedrine or pseudoephedrine products is of statewide concern. The regulation of sales pursuant to this section is not subject to further regulation by a county, city, town or other political subdivision of this state.